COVID-19 Disease and Vaccine Status In Tuberculosis Patients In Sakarya

Enes Ahmet Güven; Selin Tunalı Çokluk; Neşe Aşıcı; Fulya Aktan Kibar; İsmail Onur; Zeynep Devran Muharremoğlu; Şeyda Tok; Aziz Öğütlü

Makale detayları

COVID-19 Disease and Vaccine Status In Tuberculosis Patients In Sakarya

Yazarlar:

Enes Ahmet Güven | Selin Tunalı Çokluk | Neşe Aşıcı | Fulya Aktan Kibar | İsmail Onur | Zeynep Devran Muharremoğlu | Şeyda Tok | Aziz Öğütlü

Yayıncı:

Ondokuz Mayıs University

Ana Başlıklar:

Health Care Administration

Dergi:

Deneysel ve Klinik Tıp Dergisi Vol.40 Issue 2, pp.324-328

Belge Tipi:

Makale

Yayın Tarihi:

7/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001293719

pISSN:

1309-4483

Anahtar kelimeler:

Özet:

 Tuberculosis was the leading cause of death worldwide before COVID-19. The present study aimed to examine the cases of COVID-19 disease and vaccination against COVID-19 in patients receiving tuberculosis treatment in Sakarya. In this descriptive study, 132 people aged 18 years and over, registered in Sakarya Tuberculosis Dispensary and continuing treatment in 2021, were included. Cases of COVID-19, hospitalization, intensive care unit ICU status and vaccination status against COVID-19 were recorded. Statistical significance level was accepted as p0.05. The mean age of the patients was 49.820.6 years. 65.2 of the patients were male n86. It has been determined that 21.2 n28 of the patients have been diagnosed with COVID19. No statistically significant difference was observed between the patients gender and history of COVID-19 infection with mortality p0.05. There was no statistically significant difference between the ages of groups with and without COVID-19 p0.05. Age was statistically significantly different in the surviving and deceased groups p0.05. There was a statistically significant difference between the vaccination status of the patients and mortality p0.05.People being treated for tuberculosis are at risk as long as the danger of COVID-19 continues. More emphasis should be placed on the importance of vaccination against COVID-19, especially in elderly individuals receiving tuberculosis treatment.

 Tuberculosis was the leading cause of death worldwide before COVID-19. The present study aimed to examine the cases of COVID-19 disease and vaccination against COVID-19 in patients receiving tuberculosis treatment in Sakarya. In this descriptive study, 132 people aged 18 years and over, registered in Sakarya Tuberculosis Dispensary and continuing treatment in 2021, were included. Cases of COVID-19, hospitalization, intensive care unit ICU status and vaccination status against COVID-19 were recorded. Statistical significance level was accepted as p0.05. The mean age of the patients was 49.820.6 years. 65.2 of the patients were male n86. It has been determined that 21.2 n28 of the patients have been diagnosed with COVID19. No statistically significant difference was observed between the patients gender and history of COVID-19 infection with mortality p0.05. There was no statistically significant difference between the ages of groups with and without COVID-19 p0.05. Age was statistically significantly different in the surviving and deceased groups p0.05. There was a statistically significant difference between the vaccination status of the patients and mortality p0.05.People being treated for tuberculosis are at risk as long as the danger of COVID-19 continues. More emphasis should be placed on the importance of vaccination against COVID-19, especially in elderly individuals receiving tuberculosis treatment.

 Tuberculosis was the leading cause of death worldwide before COVID-19. The present study aimed to examine the cases of COVID-19 disease and vaccination against COVID-19 in patients receiving tuberculosis treatment in Sakarya. In this descriptive study, 132 people aged 18 years and over, registered in Sakarya Tuberculosis Dispensary and continuing treatment in 2021, were included. Cases of COVID-19, hospitalization, intensive care unit ICU status and vaccination status against COVID-19 were recorded. Statistical significance level was accepted as p0.05. The mean age of the patients was 49.820.6 years. 65.2 of the patients were male n86. It has been determined that 21.2 n28 of the patients have been diagnosed with COVID19. No statistically significant difference was observed between the patients gender and history of COVID-19 infection with mortality p0.05. There was no statistically significant difference between the ages of groups with and without COVID-19 p0.05. Age was statistically significantly different in the surviving and deceased groups p0.05. There was a statistically significant difference between the vaccination status of the patients and mortality p0.05.People being treated for tuberculosis are at risk as long as the danger of COVID-19 continues. More emphasis should be placed on the importance of vaccination against COVID-19, especially in elderly individuals receiving tuberculosis treatment.

 Tuberculosis was the leading cause of death worldwide before COVID-19. The present study aimed to examine the cases of COVID-19 disease and vaccination against COVID-19 in patients receiving tuberculosis treatment in Sakarya. In this descriptive study, 132 people aged 18 years and over, registered in Sakarya Tuberculosis Dispensary and continuing treatment in 2021, were included. Cases of COVID-19, hospitalization, intensive care unit ICU status and vaccination status against COVID-19 were recorded. Statistical significance level was accepted as p0.05. The mean age of the patients was 49.820.6 years. 65.2 of the patients were male n86. It has been determined that 21.2 n28 of the patients have been diagnosed with COVID19. No statistically significant difference was observed between the patients gender and history of COVID-19 infection with mortality p0.05. There was no statistically significant difference between the ages of groups with and without COVID-19 p0.05. Age was statistically significantly different in the surviving and deceased groups p0.05. There was a statistically significant difference between the vaccination status of the patients and mortality p0.05.People being treated for tuberculosis are at risk as long as the danger of COVID-19 continues. More emphasis should be placed on the importance of vaccination against COVID-19, especially in elderly individuals receiving tuberculosis treatment.

Makale detayları

COVID-19 Disease and Vaccine Status In Tuberculosis Patients In Sakarya

Yazarlar:

Enes Ahmet Güven | Selin Tunalı Çokluk | Neşe Aşıcı | Fulya Aktan Kibar | İsmail Onur | Zeynep Devran Muharremoğlu | Şeyda Tok | Aziz Öğütlü

Yayıncı:

Ondokuz Mayıs University

Ana Başlıklar:

Health Care Administration

Dergi:

Deneysel ve Klinik Tıp Dergisi Vol.40 Issue 2, pp.324-328

Belge Tipi:

Makale

Yayın Tarihi:

7/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001293719

pISSN:

1309-4483

COVID-19

tuberculosis

vaccination

mortalityCOVID-19

tuberculosis

vaccination

mortality

Sayı

Makale detayları

Yazarlar: Enes Ahmet Güven | Selin Tunalı Çokluk | Neşe Aşıcı | Fulya Aktan Kibar | İsmail Onur | Zeynep Devran Muharremoğlu | Şeyda Tok | Aziz Öğütlü

Yayıncı: Ondokuz Mayıs University

Ana Başlıklar: Health Care Administration

Dergi: Deneysel ve Klinik Tıp Dergisi Vol.40 Issue 2, pp.324-328

Belge Tipi: Makale

Yayın Tarihi: 7/2023

Belge Dili: İngilizce

Document ID (Org No.): 2001293719

pISSN: 1309-4483

Sayı

Yazarlar:

Enes Ahmet Güven | Selin Tunalı Çokluk | Neşe Aşıcı | Fulya Aktan Kibar | İsmail Onur | Zeynep Devran Muharremoğlu | Şeyda Tok | Aziz Öğütlü

Yayıncı:

Ondokuz Mayıs University

Ana Başlıklar:

Health Care Administration

Dergi:

Deneysel ve Klinik Tıp Dergisi Vol.40 Issue 2, pp.324-328

Belge Tipi:

Makale

Yayın Tarihi:

7/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001293719

pISSN:

1309-4483